Abe K et al. |
Phosphorylation of coagulation factor II by phospholipid/Ca(2+)-dependent protein kinase (protein kinase C). |
1991 |
Biochem. Biophys. Res. Commun. |
pmid:2039497
|
Zaidi R and Hadi SM |
Complexes involving gossypol, DNA and Cu(II). |
1992 |
Biochem. Int. |
pmid:1290468
|
Tuhácková Z |
Staurosporine and gossypol are inhibitors of the function of peptide elongation factor 1 alpha from rabbit reticulocytes. |
1994 |
Biochem. Mol. Biol. Int. |
pmid:8032322
|
Gerez de Burgos NM et al. |
Inhibition by gossypol of oxidoreductases from Trypanosoma cruzi. |
1984 |
Biochem. Pharmacol. |
pmid:6370265
|
Yu Y et al. |
Selective active site inhibitors of human lactate dehydrogenases A4, B4, and C4. |
2001 |
Biochem. Pharmacol. |
pmid:11377399
|
Zhang M et al. |
Molecular mechanism of gossypol-induced cell growth inhibition and cell death of HT-29 human colon carcinoma cells. |
2003 |
Biochem. Pharmacol. |
pmid:12818369
|
Janero DR and Burghardt B |
Protection of rat myocardial phospholipid against peroxidative injury through superoxide-(xanthine oxidase)-dependent, iron-promoted Fenton chemistry by the male contraceptive gossypol. |
1988 |
Biochem. Pharmacol. |
pmid:2840914
|
Laughton MJ et al. |
Antioxidant and pro-oxidant actions of the plant phenolics quercetin, gossypol and myricetin. Effects on lipid peroxidation, hydroxyl radical generation and bleomycin-dependent damage to DNA. |
1989 |
Biochem. Pharmacol. |
pmid:2476132
|
Burgos C et al. |
In vitro inhibition by gossypol of oxidoreductases from human tissues. |
1986 |
Biochem. Pharmacol. |
pmid:3754138
|
Cooke E et al. |
Diacylglycerol kinase inhibitor, R59022, potentiates neutrophil oxidase activation by Ca2+-dependent stimuli. Evidence for two separate but convergent pathways. |
1987 |
Biochem. Pharmacol. |
pmid:2823820
|
Marzo I and Naval J |
Bcl-2 family members as molecular targets in cancer therapy. |
2008 |
Biochem. Pharmacol. |
pmid:18638457
|
Etxebarria A et al. |
Regulation of antiapoptotic MCL-1 function by gossypol: mechanistic insights from in vitro reconstituted systems. |
2008 |
Biochem. Pharmacol. |
pmid:18762177
|
de Peyster A et al. |
Membrane structural/functional perturbations induced by gossypol. Effects on membrane order, liposome permeability, and insulin-sensitive hexose transport. |
1986 |
Biochem. Pharmacol. |
pmid:3533079
|
Rajpurohit R and Giridharan N |
Failure of oral gossypol to inhibit hepatic microsomal and cytosolic drug-metabolising enzymes. |
1988 |
Biochem. Pharmacol. |
pmid:3202895
|
Lin TS et al. |
Anti-HIV-1 activity and cellular pharmacology of various analogs of gossypol. |
1993 |
Biochem. Pharmacol. |
pmid:8347147
|
Bugeja V et al. |
Primary mitochondrial activity of gossypol in yeast and mammalian cells. |
1988 |
Biochem. Pharmacol. |
pmid:2461202
|
Javed MH and Waqar MA |
Protective effect of histidine by inhibition of gossypol on rat's liver LDH-5. |
1995 |
Biochem. Soc. Trans. |
pmid:8654811
|
Denisov AY et al. |
Heat-induced dimerization of BCL-xL through alpha-helix swapping. |
2007 |
Biochemistry |
pmid:17223694
|
Yu BZ et al. |
Gossypol modification of Ala-1 of secreted phospholipase A2: a probe for the kinetic effects of sulfate glycoconjugates. |
1997 |
Biochemistry |
pmid:9376343
|
Rosenberg LJ et al. |
Inhibition of DNA polymerase alpha by gossypol. |
1986 |
Biochim. Biophys. Acta |
pmid:3697356
|